Third-generation cancer immunotherapy, a method of removing cancer using the body’s immune system, has shown remarkable clinical benefits in recent years, giving hopes to many
Read more
Home »
An immunotherapy combination could be better than standard “Extreme” chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or
Read more
Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one
Read more
An immunotherapy based on supercharging the immune system’s natural killer cells has been effective in treating patients with recurrent leukemia and other difficult to treat
Read more
A new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients, a breakthrough that could extend to the treatment
Read more
NEW YORK (Reuters Health) – Chronic immune-related adverse events (irAEs) associated with anti-programmed cell death-1 (PD-1) therapy for melanoma were more common than previously thought
Read more
More than five years after receiving an experimental immunotherapy drug, half of a group of people at high risk of developing Type 1 diabetes remained
Read more
For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15
Read more
A Ludwig Cancer Research study has uncovered a mechanism by which the tumor’s harsh internal environment sabotages T lymphocytes, leading cellular agents of the anticancer
Read more
Researchers have created a mathematical model that can determine the impact of the immune system on tumor evolution. The information gained from using this model
Read more